Nanomedicine for the management of rheumatoid arthritis: current status and prospective therapeutic approaches
Open Access
- 28 April 2025
- journal article
- review article
- Published by Springer Nature in Discover Medicine
- Vol. 2 (1) , 1-32
Abstract
No abstract availableKeywords
This publication has 177 references indexed in Scilit:
- Photosensitizer Anchored Nanoparticles: A Potential Material for Photodynamic TherapyChemistrySelect, 2022
- Tocilizumab–Conjugated Polymer Nanoparticles for NIR‐II Photoacoustic‐Imaging‐Guided Therapy of Rheumatoid ArthritisAdvanced Materials, 2020
- Cationic Block Copolymer Nanoparticles with Tunable DNA Affinity for Treating Rheumatoid ArthritisAdvanced Functional Materials, 2020
- Correlation of the Multi‐Biomarker Disease Activity Score With Rheumatoid Arthritis Disease Activity Measures: A Systematic Review and Meta‐AnalysisArthritis Care & Research, 2019
- Mesoporous Silica Nanoparticles for Drug DeliveryAdvanced Functional Materials, 2019
- Hyaluronan‐CD44/RHAMM interaction‐dependent cell proliferation and survival in lung cancer cellsMolecular Carcinogenesis, 2018
- Reductions in Radiographic Progression in Early Rheumatoid Arthritis Over Twenty‐Five Years: Changing Contribution From Rheumatoid Factor in Two Multicenter UK Inception CohortsArthritis Care & Research, 2017
- Editorial: The Multi‐Biomarker Disease Activity Test for Rheumatoid Arthritis: Is It a Valid Measure of Disease Activity?Arthritis & Rheumatology, 2016
- Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid ArthritisArthritis & Rheumatology, 2016
- Head‐to‐head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized studyArthritis & Rheumatism, 2012